
What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients
Fox News
"GLP-3" breakthrough drug retatrutide by Eli Lilly shows major weight loss in clinical trials. The triple-agonist medication targets three hormones, with positive results.
Angelica Stabile is a lifestyle reporter for Fox News Digital.
The informal term "GLP-3" refers to a new triple-agonist drug that targets three hormones: GLP-1, GIP (glucose-dependent insulinotropic polypeptide, another naturally occurring hormone released by the gut after eating) and glucagon receptors. The most advanced example is retatrutide by Eli Lilly, according to clinical trial outcomes.

Airlines prepare for record-breaking spring break travel surge as Americans 'prioritize experiences'
U.S. airlines are preparing for record spring travel, with 171 million passengers expected between March and April, marking a 4% increase from last year.

Chloe Cole reveals intense pressure to transition as a minor, parents were told she'd 'probably die’
Chloe Cole sued Kaiser Permanente, alleging fraud and malpractice related to her medical transition as a minor, including puberty blockers, testosterone and a double mastectomy.











